Baxter International Inc (BAX.xnys)

Baxter International Inc (BAX.xnys)

Charts by TradingView

Pricing is indicative. Past performance is not a reliable indicator of future results. Log in to see latest markets data.

Baxter International Inc (BAX.xnys) Profile

Baxter International Inc (BAX.xnys) is a global health care company with headquarters in Illinois, America. Baxter Inc. operates two businesses: BioScience and Medical Products to treat kidney disease and other chronic and acute medical conditions. Both businesses produce recombinant and blood plasma proteins to treat hemophilia and other bleeding disorders, inhalational anaesthetics and products to treat end-stage kidney disease or irreversible kidney failure, including peritoneal dialysis and hemodialysis. The company has 75 office locations across 40 countries and employs 48,000 people (2017). Baxter International Inc. (BAX.xnys) is listed on the New York Stock Exchange (NYSE), has a market cap of $38.07B (USD) as of November 2021 and an $11.67B (USD) 2020 annual revenue. Baxter is the parent company of 47 subsidiaries, including GAMBRO, CHEETAH Medical Inc., Baxter S.p.A, APATECH Limited, Synovis Micro Companies Alliance Inc. The company announced the expansion of $100M (USD) of its sterile fill/finish manufacturing facility which is operated by BioPharma Solutions (BPS), located in Halle, Germany. Baxter's business unit BioPharma specialises in partnering with leading pharmaceutical and biotech companies to develop and contract drug products for parenteral pharmaceuticals. The construction of the new manufacturing building is expected to begin in 2022 and be completed in 2024.

Holding cost
Trading hours in US Eastern Time

Start Trading Baxter International Inc (BAX.xnys)
with a Market Leader Today

Share CFD Trading FAQ

Each investor owning shares of a company is also owning fragments of the company. A quite simple way to explain what a stock is is basically when a company divides itself into several shares and then it makes a part of these equities available to the public, at a price. Each investor owning shares of a company is owning fragments of the company.

While shares represent units of ownership within a company Contracts for Difference (CFDs) allow traders to speculate on the future share price fluctuations of an underlying asset. Thus when trading CFDs traders do not physically own the underlying asset. CFDs are available for a range of underlying assets, such as shares, commodities, and foreign exchange, and indices.

6 Reasons to Trade Share
CFDs with FP Markets

An Australian-regulated
forex & CFD broker

Go Long or Short

Increase your ability to profit in all market conditions Leverage options up to 20:1

Direct Market Access (DMA) Execution

Real-time, transparent share prices Control, Functionality and deep liquidity Full Market depth & see your orders in the queue

Advanced Platforms
& Technology

MT4, MT5, Webtrader & Iress with superior client portal

24/5 Multilingual
Customer Support

Award winning support & personal account managers

Global Exposure

Low margins and competitive commission +10,000 products on global stocks across 4 continents

Earn Dividends

On long positions No ownership of physical shares necessary

Start Trading
in Minutes

Open an account now

bullet Access 10,000+ financial instruments
bullet Auto open & close positions
bullet News & economic calendar
bullet Technical indicators & charts
bullet Many more tools included

By supplying your email you agree to FP Markets privacy policy and receive future marketing materials from FP Markets. You can unsubscribe at any time.

Get instant Updates in Telegram
Sitemap | © FP Markets 2022